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Abstract
Background: Fuyu city in China has a high prevalence of hepatitis C virus (HCV) infection resulting in a high
morbidity and mortality from chronic liver disease and hepatocellular carcinoma. This study was conducted to
identify the risk factors for HCV infection in Fuyu city.
Methods: Recruitment of study subjects involved a cross-sectional survey using non-random, convenience sampling.
Information on demographic variables, risk factors for HCV infection, clinical manifestations, behavioral practices and
family history was collected by administering a questionnaire. Anti-HCV antibody was detected using Abbott
ARCHITECT i2000SR. HCV infection was confirmed by HCV-RNA testing by the Roche Taqman HCV test.
Univariate and multivariate analyses were performed to identify the factors associated with HCV infection.
Results: Out of 3,228 persons that participated in the survey, 3,219 were enrolled in the study. The prevalence of HCV
infection was 42.1 % (1355/3219). Among 734 patients with chronic HCV infection whose HCV-RNA genotyping was
performed, genotype 1b was the most common (58.0 %), followed by genotype 2a (40.2 %), while co-infection with
genotypes 1b and 2a was detected in 1.8 % of the subjects. On univariate analysis, male gender, older age, parenteral
caffeinum natrio-benzoicum and share syringes (PCNBSS), and nine other factors were significantly associated with HCV
infection. After adjusting for potential confounders, male gender, old age, cigarette smoking, lower education level,
history of blood transfusion, blood donation, prior dental surgery, and PCNBSS were found to be independently
associated with HCV infection.
Conclusions: The prevalence of HCV infection is likely to be high among residents in Fuyu and we observed that
genotypes 1b and 2a dominated in the city. Our findings support the hypothesis that PCNBSS which became endemic
in Fuyu city during 1970s-1980s is strongly associated with HCV positivity.
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Introduction
In recent years, a majority of patients with hepatitis
C virus (HCV) infection admitted at our hospital were resi-
dents of Fuyu City, which is located in Northwest region of
Jilin Province, China. The city has a heavy burden of liver
disease, most likely attributable to chronic HCV infection
[1]. According to official figures, the incidence of HCV
infection in Jilin province in year 2012 was higher (0.31‰)
than the average incidence reported in the mainland China
(0.16 ‰) [2]. A rampant use of parenteral caffeinum
natrio-benzoicum with shared syringes (PCNBSS) during
mass celebrations is the likely mode of transmission of
blood-borne pathogens, including HCV in Fuyu city.
Caffeinum natrio-benzoicum (CNB), also known as
caffeine and sodium benzoate, is used as a psychotropic
drug. Caffeine has an excitatory effect on the nervous
system, while sodium benzoate assists in solubilization
and absorption of caffeine. In the 1970s, certain popula-
tion groups in north, northeast and northwest regions of
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China started abusing CNB through oral or nasal inhal-
ation (snorting). Around the same time, residents in
Fuyu developed the habit of recreational use of paren-
teral CNB during community celebrations. Similar rec-
reational use of CNB has not been reported from any
other part of the world. Parenteral abuse of CNB during
celebrations has earlier been implicated as a risk factor
for acquisition of HCV and hepatitis B virus (HBV) in-
fection in China [3]. Caffeinum natrio-benzoicum has
been listed as a psychotropic drug and its abuse has
been forbidden in China since 1988.
We investigated the relative importance of PCNBSS
in the spread of HCV infection in the Fuyu City by
comparing cumulative lifetime exposure to PCNBSS
with the current specific prevalence of HCV infection.
We hypothesized that the parenteral abuse of CNB during
celebrations coupled with inadequately sterilized drug
injecting paraphernalia was a major factor in the spread of
HCV infection in Fuyu City.
Methods
Study population and recruitment
The target population was permanent residents in Fuyu
City. In September 2012, we conducted a cross-sectional
survey using non-random, convenience sampling in
Fuyu City, Jilin Province, China. In the first stage, five
survey locations (Township Health Center) were obtained
from all the 5 towns in Fuyu City (Desheng, Gengxin,
Wanfa, Dalinzi and Gongpengzi). In the second stage,
more than 100 village committee members and rural
doctors in all the 5 towns in Fuyu City were recruited
and trained for two days on effective publicity for the
survey. They then publicized the study in their village
using recruitment cards and flyers which was necessary
for the investigators to perform cluster sampling. In the
third stage, our research team performed the survey for
5–8 days at each survey location. Enrolled participants
were encouraged to inform their peers about the study.
Individuals were eligible to participate, if they were
current residents of Fuyu city, and consented to undergo
laboratory investigations for HCV, HBV and HIV. After
screening for eligibility and obtaining informed consent,
each subject was made to complete a questionnaire. Par-
ticipants who did not complete the questionnaire were
excluded from the study. Subjects were asked to return
4–6 weeks later to receive the laboratory test results.
Those subjects who were diagnosed with HCV and/or
HBV infection were referred to a medical center for fur-
ther treatment and care.
Data collection
Each subject was asked to complete a questionnaire that
included information on demographic variables (age,
gender and race), risk factors for HCV infection, clinical
manifestations, behavioral activity, and family history.
Clinical information included the presence or absence
of diabetes, thyroid disease, autoimmune disorders, previ-
ous history of surgery, blood transfusion, blood donation,
and antiviral treatment, and family history of liver disease.
Behavioral information regarding injection drug use
(especially parenteral CNB, frequency of use, and date
of first/last injection), alcohol abuse, and cigarette
smoking was collected. The subject’s age at the time of
first use of injectable drug was also recorded.
Virological detection
Blood samples were tested for Hepatitis B surface antigen
(HBsAg), and antibodies against HBsAg (anti-HBsAg),
Hepatitis B core antigen (anti-HBc),Hepatitis C (Anti-
HCV) and HIV using Abbott ARCHITECT i2000SR Im-
munoassay System (Abbott Laboratories; Abbott Park, IL,
USA) at the clinical laboratory of the First Hospital of Jilin
University. All samples that were anti-HCV positive were
confirmed by HCV-RNA test (COBAS AmpliPrep/
TaqMan, Roche Diagnostics Ltd, Rotkreuz, Switzerland).
Anti-HCV positive results were confirmed by recombin-
ant immune blot assay (CHIRON RIBA HCV 3.0 SIA,
Ortho Clinical Diagnostics, Johnson & Johnson, USA)
in individuals who subsequently tested negative for
HCV-RNA. HCV genotyping was performed by multi-
color fluorescence polymerase chain reaction (PCR)
using an HCV-RNA genotyping kit (BioAssay Science
& Technology Co. Ltd., Beijing, China).
Statistical analysis
Statistical analyses were performed using the statistical
software R for Windows, version 3.1.1. Continuous vari-
ables were expressed as median and inter-quartile range
(IQR) or mean and standard deviation, as appropriate,
and were compared using the Student t-test or the
Mann–Whitney U-test. Categorical variables were com-
pared using the Chi-square test or the Fisher’s exact test.
Variables with statistical significance (P ≤0.05) in the
univariate model were analyzed using a multivariate logis-
tic regression model. All variables found to be significant
(P ≤0.05) through univariate analysis were considered for
inclusion in multivariable analysis. A backward stepwise
logistic regression was performed, and factors that were
statistically significant (P ≤0.05) in multivariable analysis
remained in the final model. A P-value ≤0.05 was consid-
ered statistically significant; Odds ratio (OR) with 95 %
Confidence Interval (CI) are presented to demonstrate the
strength and direction of these associations.
Ethical considerations
The study was approved by the Ethics Committee at
the First Hospital of Jilin University, Changchun, China.
Written informed consent was obtained from all
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participants before initiating any study-specific proced-
ure. Due care was taken to incorporate specific proto-
cols aimed at maintaining data confidentiality, as well
as to protect the subjects against potential ethical viola-
tion. Data collection was usually conducted at the town-
ship Health Center. At the time of filling of questionnaire
by the participants, presence of both interviewee and
interviewer was made mandatory. All necessary precau-
tions for obtaining data confidentially were taken (the
questionnaire was applied only in the presence of the
interviewee and interviewer). Those agreeing to take part
in the study were asked to have their blood collected at
the university hospital laboratory for further evaluation of
anti-HCV and anti-HBV activity, always in the presence of
the researcher.
Results
Demographic characteristics and prevalence of HBV, HCV
and HIV infection
Out of 3,228 persons who participated in the survey,
3,219 (male, 1536 [47.7 %]; female, 1683 [52.3 %]) were
enrolled in the study. Data pertaining to 9 participants
was excluded due to incomplete or unreliable informa-
tion. Out of 3219 study subjects, 2,182 (67.8 %) were
aged between 40 and 60 years. Overall, the prevalence
of HCV and HBV mono-infection was 39.8 % (95 %
CI: 38.1 %–41.5 %) and 5 % (95 % CI: 4.2 %–5.8 %)
respectively, the prevalence of HBV/HCV co-infection
was 2.9 % (95 % CI: 2.3 %–3.5 %). HCV-RNA geno-
typing was performed on 873 subjects with chronic
HCV infection. There were 139 subjects with chronic
HCV infection in whom HCV-RNA genotyping was not
possible due to low HCV-RNA levels. Genotype 1b was
the most common HCV genotype (426/734, 58.0 %)
followed by genotype 2a (295/734, 40.2 %). Co-infection
with HCV genotypes 1b and 2a was detected in 1.8 % sub-
jects. Hepatitis C virus load range from 0 IU/ml to
111700000 IU/ml and the median viral load was 577000
IU/ml among HCV positive participants (Clinical and
virological characteristics of the HCV positive partici-
pants are supplied in Additional file 1). None of the
study subjects tested positive for HIV infection.
Univariate analysis of variables associated with HCV
infection
The results of univariate analysis are presented in Table 1.
The results showed that 795 (24.7 %) participants were ex-
posed to PCNBSS in their lifetime. Participants with a his-
tory of exposure to PCNBSS were more likely to get HCV
infection (73.5 %). Male gender (OR = 2.17, 95 % CI:
1.89–2.51), older age (OR = 3.27, 95 % CI: 2.83–3.79),
lower educational level (OR = 4.21, 95 % CI: 1.48–5.72;
OR = 5.92, 95 % CI: 3.19–10.99), cigarette smoking
(OR = 2.17, 95 % CI: 2.35–3.13), alcohol consumption
(OR = 2.09, 95 % CI: 1.80–2.42), history of blood trans-
fusion (OR = 1.71, 95 % CI: 1.17–2.50), prior dental
surgery (OR = 1.49, 95 % CI: 1.29–1.71), and PCNBSS
(OR = 5.93, 95 % CI: 4.96–7.10) were significantly asso-
ciated with an increased risk of HCV infection. Factors
negatively associated with HCV infection were non-
farming occupation (OR = 0.23, 95 % CI: 0.16–0.33),
ear piercing (OR–0.54, 95 % CI: 0.47–0.62), blood donation
(OR–0.35, 95 % CI: 0.20–0.59), and tattoo (OR = 0.34, 95 %
CI: 0.22–0.53).
Multivariate analysis of variables associated with HCV
infection
Gender, age, cigarette smoking, PCNBSS, occupation, edu-
cation, blood transfusion, blood donation, prior dental
surgery, ear piercing, tattooing, alcohol consumption, and
HBV infection, which were associated with HCV infection
in univariate analysis, were considered for entry in
multivariable analysis. After adjusting for potential
confounders, male gender (OR = 2.06, P <0.001), older
age (OR = 2.78, P <0.001), cigarette smoking (OR = 1.85,
P <0.001), lower educational level (RR = 2.13, P <0.001),
history of blood transfusion (OR = 1.68, P <0.05), prior
dental surgery (OR = 1.21, P <0.05), and PCNBSS
(OR = 4.90, P <0.001) were independently associated
with HCV infection on multivariate analysis (Table 2).
The most significant risk factor found in our study
was PCNBSS, with a prevalence of 24.7 % among
study subjects. Ear piercing, tattoo, alcohol consump-
tion, occupation and HBV infection were not found
to be statistically associated with HCV infection in
this study.
Discussion
In this study, the prevalence of HCV infection in Fuyu
City was found to be 42.7 %, which was approximately
100-fold higher than the national rate (0.43 %) [4, 5].
The most common genotypes of HCV circulating in
Fuyu City were 1b and 2a, which is consistent with the
other studies conducted in East Asia [6, 7]. Several studies
have reported a higher risk of HCV infection in profes-
sional blood donors, patients on hemodialysis, hemophil-
iacs, injection drug users (IDUs), men who have sex with
men, and those with multiple sex partners [8–11]. In the
present study, important risk factors associated with HCV
transmission were PCNBSS, history of blood transfusion
and prior dental surgery. The other significant risk factors
for transmission of HCV included farming as an occupa-
tion, older age, male gender, and cigarette smoking. The
risk factor most strongly associated with HCV infection
was PCNBSS which supports the hypothesis that PCNBSS
was an important predisposing factor for establishment of
a large reservoir of HCV infection in Fuyu City. The re-
sults of the regression analysis confirmed the strong
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association between PCNBSS and HCV infection, even
after adjusting for other confounding variables.
In our earlier study conducted in Changchun ling, a
village near Fuyu City, where the custom of PCNBSS
abuse during ceremonies was not practiced, the prevalence
of HCV infection was found to be only 3.9 % [1]. These
contrasting findings strongly implicate PCNBSS as a factor
responsible for the wide variability in the prevalence of
HCV infection in two geographically contiguous areas.
In this study, prevalence of HCV infection was higher
in males >50 years old. This is consistent with the as-
sumption that recreational use of PCNBSS started in
1970s and 1980s when these people were old enough to
participate in the wedding and funeral ceremonies, dur-
ing which exposure to PCNBSS occurred. According to
the national epidemiological survey of viral hepatitis
conducted in China from 1991 to 1995, there was no
significant difference in the prevalence of HCV infec-
tion between males and females [12]. Similar findings
of a higher HCV prevalence in elderly males has also
been reported from an Egyptian study [13]. However,
a Taiwanese study involving 23820 participants reported a
higher sero-prevalence of HCV infection in females than
in males [14]. In our study, HCV infection rate in males
(51.9 %) was higher than that in females (33.2 %), while the
males had an increased chance of exposure to PCNBSS.
In the multivariate model, a history of blood transfu-
sion and prior dental surgery were significant risk factors
associated with HCV infection, which suggests that un-
safe medical practices may have contributed to HCV
transmission. Since limited resources are available for
prevention of HCV infection, the focus should be directed
Table 1 Univariate analysis of socio-demographic characteristics by HCV status among residents in Fuyu City, China
Variable Total N (%) HCV + N (%) Odds ratio (95 % CI) χ2 P value
Sex female 1683 (100) 558 (33.2) 2.17 (1.89–2.51) 115.6 <0.001
Male 1536 (100) 797 (51.9)
Age <50 years old 1575 (100) 438 (27.8) 3.27 (2.83–3.79) 258.2 <0.001
>50 years old 1644 (100) 917 (55.8)
Education college 138 (100) 11 (8.0) 55.4 <0.001
middle school 805 (100) 270 (33.5) 4.21 (2.24–7.90)
primary school 2276 (100) 1074 (47.2) 5.92 (3.19–10.99)
Occupation farmer 3032 (100) 1327 (43.8) 0.23 (0.16–0.33) 59.9 <0.001
non-farmer 187 (100) 28 (15.0)
Cigarette smoking No 1684 (100) 517 (30.7) 2.17 (2.35–3.13) 188.1 <0.001
Yes 1535 (100) 838 (54.5)
Alcohol consumption No 2138 (100) 771 (36.1) 2.09 (1.80–2.42) 95.5 <0.001
Yes 1081 (100) 584 (54.1)
HBV infection no 2966 (100) 1262 (42.5) 0.785 (0.602–1.024) 2410 <0.001
yes 253 (100) 963 (36.7)
PCNBSS no 2424 (100) 771 (31.8) 5.93 (4.96–7.10) 426.1 <0.001
yes 795 (100) 584 (73.5)
Surgery no 1814 (100) 771 (42.5) 0.96 (0.84–1.11) 0.285 0.59
yes 1405 (100) 584 (41.6)
Ear piercing no 1927 (100) 925 (48) 0.54 (0.47–0.62) 71.1 <0.001
yes 1292 (100) 429 (33.2)
Blood transfusion no 3108 (100) 1293 (41.6) 1.71 (1.17–2.50) 9.2 <0.05
yes 111 (100) 61 (55)
Blood donation no 3136 (100) 1338 (42.7) 0.35 (0.20–0.59) 16.3 <0.001
yes 83 (100) 17 (20.5)
Tattooing no 3101 (100) 1331 (42.9) 0.34 (0.22–0.53) 24.5 <0.001
yes 118 (100) 24 (20.3)
Prior dental surgery no 1666 (100) 623 (37.4) 1.489 (1.29–1.71) 33.6 <0.001
yes 1551 (100) 730 (47.1)
HCV, Hepatitis C virus; PCNBSS, Parenteral caffeinum natrio-benzoicum and share syringes; CI, Confidence Interval
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on ensuring implementation of safe practices in healthcare
settings. To prevent nosocomial infection, mandatory
screening of blood donors for HCV should be enforced.
The Chinese government has prohibited the use of paid
blood donors since 1998, which has improved blood
safety [15]. This transition in the blood donor recruit-
ment method has been associated with a gradual decline
in the prevalence of anti-HCV among blood donors,
which is also reflected in the low prevalence of HCV in-
fection in the blood donors participating in our study.
In addition to syringe-sharing, sharing of injecting
paraphernalia is a well-recognized risk factor for HCV
infection [16]. However, in the present study ear piercing
and tattooing were significantly associated with a de-
creased risk of HCV infection on univariate analysis.
Since the older ages and male gender are risk factors for
HCV infection in our study, this outcome could have
resulted from the influence of age and sex (perhaps
females and youngsters were more likely to be involved
in these practices). After adjusting for ages, gender and
other potential confounders, the association between a
history of ear piercing or tattooing was not significant
on multivariate analysis. As PCNBSS is reported popular
in older (>50 years) male group, all of the above can
deem that PCNBSS was the independent risk factor of
HCV transmission in Fuyu city.
Since prevention messages against PCNBSS are more
prevalent than messages advising against paraphernalia
sharing, the residents in Fuyu may lack the awareness of
prevention HCV from these factors such as ear piercing
or tattooing.
Several studies have demonstrated a significant associ-
ation between lower literacy level and HCV infection
[17–19]. In the present study, people educated up to
middle or primary school education had a higher preva-
lence of HCV infection as compared to those who had
completed college education. Further, HCV infected in-
dividuals were more likely to have unhealthy habits like
cigarette smoking, which is also consistent with other
studies [20].
Currently available antiviral regimes for treatment of
HCV infection have a high efficacy with a sustained viro-
logical response rate close to 100 % if treatment is
started early during the acute phase [21]. Unfortunately,
most cases of HCV are diagnosed when chronic infec-
tion is already established, which makes spontaneous
viral clearance difficult in these patients. Some HCV
positive subjects were not aware of their seropositive sta-
tus before their enrollment in this study. It is likely that
in these subjects, the risk behaviors for HCV transmis-
sion may have been influenced by their new found sero-
positive status, possibly contributing to minimizing other
risky behavior such as sharing toothbrush with families.
Furthermore, these HCV positive subjects were willing to
get earlier treatment to prevent the development of
chronic liver disease and hepatocellular carcinoma. There-
fore, there is a pressing need for one-time screening for
HCV infection in populations with high-risk behavior.
PCNBSS appears to be the most important risk factor
for HCV infection in Fuyu. Other factors also contribute
to the transmission of HCV in the city. Ongoing re-
search is required to assess the emerging risk of trans-
mission. Most of the HCV infected subjects in this study
were males. Further research is needed to understand
how familial transmission occurs with regard to spouses
and children. Given the high risk of infection transmis-
sion among family members of HCV-infected individ-
uals, awareness raising activities are urgently needed.
Use of a non-random convenience sample and self-
reporting of at-risk behaviors by subjects are key limi-
tations of our study. The study sample may not be
representative of the general population in Fuyu. Similarly
Table 2 Multivariate regression analysis of factors associated with Hepatitis C virus infection among residents in Fuyu City, China
Variable B S.E. Wald P value OR 95 % CI for OR
Sex 0.72 0.09 66.77 <0.001 2.06 1.73–2.45
Age 1.02 0.09 141.76 <0.001 2.78 2.35–3.95
Cigarette smoking 0.61 0.08 52.82 <0.001 1.85 1.57–2.18
PCNBSS 1.59 0.10 252.87 <0.001 4.90 4.03–5.96
Prior dental surgey 0.19 0.08 5.20 <0.05 1.21 1.03–1.43
Blood transfusion 0.52 0.22 5.45 <0.05 1.68 1.09–2.61
Education
Primary school Reference Reference Reference Reference Reference Reference
Middle school −0.70 0.10 45.37 <0.001 0.50 0.41–0.61
College −1.83 0.34 29.43 <0.001 0.16 0.08–0.31
Blood donation −0.76 0.34 4.95 <0.05 0.47 0.24–0.91
Constant −0.47 0.42 1.26 0.26 0.62
PCNBSS, parenteral caffeinum natrio-benzoicum and share syringes; S.E., Standard Error
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self-reporting by subjects could have been affected by
recall bias. In order to minimize recall bias, questions
related to substance use and injection behavior recall
(such as when and where did you take the PCNBSS) were
kept in the questionnaire. Despite these limitations, the
survey demonstrated a high prevalence of HCV infections
in Fuyu city where PCNBSS was most important risk
factors for HCV transmission.
Conclusion
The prevalence of HCV infection is likely to be high
among residents in Fuyu and we observed that geno-
types 1b and 2a dominated in the city. Our findings
support the hypothesis that PCNBSS which became
endemic in Fuyu city during 1970s–1980s is strongly
associated with HCV positivity. More attention should
be paid to routine screening for HCV in high-risk areas.
Additional file
Additional file 1: Clinical and virological characteristics of the HCV
positive participants. (DOCX 18 kb)
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